The androgen receptor (AR) plays a central role in the oncogenesis of different tumors, as is the case in prostate cancer. In triple negative breast cancer (TNBC) a gene expression classification has described different subgroups including a luminal androgen subtype. The AR can be controlled…
Source:Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling
Wednesday, April 30, 2014
Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment